Journal Article

Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review and meta-analysis

Polanco, Patricio, Ayloo, Subhashini, Vreeland, Timothy, Onkendi, Edwin, Ansari, Mohammed T, Buell, Joseph, Shah, Mihir M, Jeyarajah, D. Rohan, Collings, Amelia T, Ozair, Ahmad, Abdalla, Moustafa, Richardson, William, Pryor, Aurora D, Ceppa, Eugene, Rahman, Faique, Awad, Ziad, Slater, Bethany J, Abou-Setta, Ahmed, Dirks, Rebecca, Kchaou, Ali, Douglas, Samuel, Nelson, Daniel, Whiteside, Jake, Alseidi, Adnan, Sucandy, Iswanto, Miraflor, Emily

2023

Overview

BackgroundPrimary hepatocellular carcinoma (HCC) and colorectal liver metastases (CRLM) represent the two most common malignant neoplasms of the liver. The objective of this study was to assess outcomes of surgical approaches to liver ablation comparing laparoscopic versus percutaneous microwave ablation (MWA), and MWA versus radiofrequency ablation (RFA) in patients with HCC or CRLM lesions smaller than 5 cm.MethodsA systematic review was conducted across seven databases, including PubMed, Embase, and Cochrane, to identify all comparative studies between 1937 and 2021. Two independent reviewers screened for eligibility, extracted data for selected studies, and assessed study bias using the modified Newcastle Ottawa Scale. Random effects meta-analyses were subsequently performed on all available comparative data.ResultsFrom 1066 records screened, 11 studies were deemed relevant to the study and warranted inclusion. Eight of the 11 studies were at high or uncertain risk for bias. Our meta-analyses of two studies revealed that laparoscopic MW ablation had significantly higher complication rates compared to a percutaneous approach (risk ratio = 4.66; 95% confidence interval = [1.23, 17.22]), but otherwise similar incomplete ablation rates, local recurrence, and oncologic outcomes. The remaining nine studies demonstrated similar efficacy of MWA and RFA, as measured by incomplete ablation, complication rates, local/regional recurrence, and oncologic outcomes, for both HCC and CRLM lesions less than 5 cm (p > 0.05 for all outcomes). There was no statistical subgroup interaction in the analysis of tumors < 3 cm.ConclusionThe available comparative evidence regarding both laparoscopic versus percutaneous MWA and MWA versus RFA is limited, evident by the few studies that suffer from high/uncertain risk of bias. Additional high-quality randomized trials or statistically matched cohort studies with sufficient granularity of patient variables, institutional experience, and physician specialty/training will be useful in informing clinical decision making for the ablative treatment of HCC or CRLM.

• Publisher: Springer Nature B.V
• Subject: Ablation / Laparoscopy / Liver cancer / Meta-analysis / Metastasis / Systematic review